Boost Mobile announces addition of LG Tribute Monarch upgrade

Boost Mobile announces addition of LG Tribute Monarch upgrade

ENGLEWOOD -- Boost Mobile announced the addition of the LG Tribute Monarch, a next-level addition to LG's Tribute Series, is available online at BoostMobile.com for the limited-time price... Read More

Wednesday July 8, 2020 0 comments Tags: Englewood, Boost Mobile

Ampio to begin first clinical trial in COVID-19 program

Ampio to begin first clinical trial in COVID-19 program

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it is developing therapies for patients infected with the SARS-CoV-2 virus ("COVID-19"). The U.S. Food and Drug... Read More

Monday June 22, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19

Ampio provides update on COVID research program

Ampio provides update on COVID research program

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE),a biopharmaceutical company focused on the advancement of immunology-basedtherapies for prevalentinflammatory conditions, announced... Read More

Tuesday May 26, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, COVID-19, Ampion

Ampio reports acceptance of publication on potential benefits of nebulized Ampion for COVID patients

Ampio reports acceptance of publication on potential benefits of nebulized Ampion for COVID patients

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE),a biopharmaceutical company focused on the development of immunology-based therapies for prevalent inflammatory conditions,... Read More

Tuesday May 12, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, COVID-19, Ampion

Metro Screenworks: Allergy Guard air filtration screen could filter COVID

Metro Screenworks: Allergy Guard air filtration screen could filter COVID

ENGLEWOOD -- Metro Screenworks Inc. announced the addition of Allergy Guard, a virus-filtering screen, to their product line-up. This screening product created by BMT utilizes the same... Read More

Monday April 20, 2020 0 comments Tags: Englewood, Metro Screenworks, Allergy Guard, COVID-19

Ampio Pharmaceutical's FDA application for Ampion clinical study to treat COVID-19 ARDS on TV

Ampio Pharmaceutical's FDA application for Ampion clinical study to treat COVID-19 ARDS on TV

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it was featured on aFOXTV segment titled, "Englewoodpharmaceutical company looking to treat COVID-19 patients with... Read More

Friday April 3, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Michael Macaluso, FDA, COVID-19, ARDS

Aytu BioScience gets FDA approval to begin distribution of COVID-19 rapid tests across U.S.

Aytu BioScience gets FDA approval to begin distribution of COVID-19 rapid tests across U.S.

ENGLEWOOD -- Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced it has received... Read More

Thursday March 26, 2020 0 comments Tags: Englewood, Aytu BioScience, John Disbrow, COVID-19

Ampio prepares FDA protocol to study Ampion as treatment for COVID-19 Acute Respiratory Distress

Ampio prepares FDA protocol to study Ampion as treatment for COVID-19 Acute Respiratory Distress

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it is preparing an expanded access FDA protocolto study potential benefit of nebulized treatment with Ampion in SARS-Cov-2... Read More

Wednesday March 25, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19